
“High risk, non–muscle invasive bladder cancer carries a significant risk of recurrence and progression. This emphasizes the need for careful patient selection, especially when we are considering bladder-sparing approaches," says Neeraja Tillu, MD.
“High risk, non–muscle invasive bladder cancer carries a significant risk of recurrence and progression. This emphasizes the need for careful patient selection, especially when we are considering bladder-sparing approaches," says Neeraja Tillu, MD.
“Identification of significant predictors [of upstaging] has improved our pre-op counseling," says Neeraja Tillu, MD.
Published: March 15th 2025 | Updated:
Published: March 25th 2025 | Updated: